sulfinpyrazone and Arterial Occlusive Diseases
sulfinpyrazone has been researched along with Arterial Occlusive Diseases in 14 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"In patients treated with sulfinpyrazone, an apparent reduction in the incidence of sudden death and presumed ventricular fibrillation has been reported." | 7.66 | Effect of sulfinpyrazone on ventricular fibrillation during acute myocardial ischemia. ( Escobinas, AJ; Jorgensen, OB; Moschos, CB; Regan, TJ, 1981) |
"In patients treated with sulfinpyrazone, an apparent reduction in the incidence of sudden death and presumed ventricular fibrillation has been reported." | 3.66 | Effect of sulfinpyrazone on ventricular fibrillation during acute myocardial ischemia. ( Escobinas, AJ; Jorgensen, OB; Moschos, CB; Regan, TJ, 1981) |
" It is concluded that when initiating and withdrawing treatment with SP in a patient receiving AC, the prothrombin time should be checked daily for a few days to adapt (reduce) the dosage of AC to the change in prothrombin time induced by SP." | 2.65 | [The effect of sulfinpyrazone on the coagulation-inhibiting action of acenocoumarol]. ( Fontanilles, F; Holt, NF; Michot, F, 1981) |
Research
Studies (14)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Comberg, HU | 1 |
Janssen, EJ | 1 |
Diehm, C | 1 |
Zimmermann, R | 1 |
Harenberg, J | 1 |
Walter, E | 1 |
Oster, P | 1 |
Allenberg, J | 1 |
Horsch, AK | 1 |
Mörl, H | 1 |
Cain, TD | 1 |
Wood, JS | 1 |
Beard, OW | 1 |
Michot, F | 1 |
Holt, NF | 1 |
Fontanilles, F | 1 |
Cristol, R | 1 |
Moschos, CB | 1 |
Escobinas, AJ | 1 |
Jorgensen, OB | 1 |
Regan, TJ | 1 |
Verstraete, M | 1 |
Vigdahl, RL | 1 |
Ferber, RH | 1 |
Parrish, SL | 1 |
Ostendorf, P | 1 |
Regli, F | 1 |
Michaud, PA | 1 |
Loew, D | 1 |
Genton, E | 1 |
Gent, M | 1 |
Hirsh, J | 1 |
Harker, LA | 2 |
Bollinger, A | 1 |
Di Perri, T | 1 |
Reviews
4 reviews available for sulfinpyrazone and Arterial Occlusive Diseases
Article | Year |
---|---|
Medical Grand Rounds: extracranial carotid artery disease.
Topics: Adolescent; Adult; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Auscultation; Carotid Art | 1980 |
[Platelet antiaggregants and arteriopathies].
Topics: Arterial Occlusive Diseases; Aspirin; Cerebrovascular Disorders; Clofibrate; Coronary Disease; Dipyr | 1981 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria | 1975 |
Antiplatelet drugs in the management of patients with thrombotic disorders.
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Blood Coagulation Disorders; Blood Platelets | 1986 |
Trials
5 trials available for sulfinpyrazone and Arterial Occlusive Diseases
Article | Year |
---|---|
[Sulfinpyrazone (Anturan) versus placebo following surgical reconstruction of the femoral artery in arterial occlusive diseases].
Topics: Adult; Aged; Arterial Occlusive Diseases; Arteriosclerosis; Clinical Trials as Topic; Double-Blind M | 1983 |
Medical Grand Rounds: extracranial carotid artery disease.
Topics: Adolescent; Adult; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Auscultation; Carotid Art | 1980 |
[The effect of sulfinpyrazone on the coagulation-inhibiting action of acenocoumarol].
Topics: Acenocoumarol; Adult; Aged; Arterial Occlusive Diseases; Blood Coagulation; Clinical Trials as Topic | 1981 |
Internation Committee on Thrombosis and Haemostasis Basil, 8.-11. September 1974 Subcommittee on Clinical Investigations: Registry of prospective clinical trials.
Topics: Ancrod; Animals; Arterial Occlusive Diseases; Aspirin; Batroxobin; Clinical Trials as Topic; Fibrino | 1975 |
Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (second of three parts).
Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Cardiac Catheterization; Clinical Tria | 1975 |
Other Studies
7 other studies available for sulfinpyrazone and Arterial Occlusive Diseases
Article | Year |
---|---|
Effect of sulfinpyrazone on ventricular fibrillation during acute myocardial ischemia.
Topics: Acute Disease; Animals; Arterial Occlusive Diseases; Blood Pressure; Coronary Disease; Dogs; Electro | 1981 |
Evaluation of antiinflammatory and antithrombotic drugs in pulmonary and arterial thrombosis.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Anti-Inflammatory Agents; Arterial Occlusive Di | 1979 |
[Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions].
Topics: Anticoagulants; Arterial Occlusive Diseases; Aspirin; Cerebral Infarction; Cerebrovascular Disorders | 1979 |
[Treatment of transient ischemic attacks (author's transl)].
Topics: Angiography; Anticoagulants; Arterial Occlusive Diseases; Aspirin; Endarterectomy; Humans; Ischemic | 1978 |
[Results of clinical studies on the effect of aggregation inhibitors in arterial diseases].
Topics: Arterial Occlusive Diseases; Aspirin; Dipyridamole; Humans; Platelet Aggregation; Sulfinpyrazone | 1979 |
[Secondary prevention of peripheral arterial occlusive diseases].
Topics: Angioplasty, Balloon; Arterial Occlusive Diseases; Aspirin; Coumarins; Dipyridamole; Humans; Sulfinp | 1987 |
[Prevention and medical treatment of polyregional vascular lesions].
Topics: Adult; Anticoagulants; Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Diet; Dipyridamole; D | 1985 |